Technical Analysis for CTKB - Cytek Biosciences, Inc.

Grade Last Price % Change Price Change
F 14.03 6.21% 0.82
CTKB closed down 3.86 percent on Tuesday, January 18, 2022, on 62 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical CTKB trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 6.21%
Lower Bollinger Band Walk Weakness 6.21%
New 52 Week Low Weakness 6.21%
Wide Bands Range Expansion 6.21%
Below Lower BB Weakness 6.21%
Lower Bollinger Band Touch Weakness 6.21%
Oversold Stochastic Weakness 6.21%
Hammer Candlestick Bullish 2.11%
Lower Bollinger Band Walk Weakness 2.11%
New 52 Week Low Weakness 2.11%
Older End-of-Day Signals for CTKB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 1 hour ago
Up 5% about 1 hour ago
Rose Above Previous Day's High about 2 hours ago
Rose Above Lower Bollinger Band about 2 hours ago
Up 3% about 2 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Cytek Biosciences, Inc. Description

Cytek Biosciences, Inc. engages in the manufacture and sale of cell analysis solutions for clinical and biomedical research in the fields of drug discovery, genomics, immuno-oncology, immuno-profiling, infectious diseases, inflammatory diseases, and multi-site standardization applications. Its instruments include the Aurora and Northern Lights systems, which are flow cytometers to deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also offers cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. Its customers include pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. Cytek Biosciences, Inc. was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. The company was incorporated in 2014 and is headquartered in Fremont, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biology Infectious Diseases Laser Antibodies Drug Discovery Cell Biology Genomics Inflammatory Diseases Medical Test Blood Test Laboratory Techniques Flow Cytometry Clinical Pathology

Is CTKB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.69
52 Week Low 13.015
Average Volume 199,934
200-Day Moving Average 0.00
50-Day Moving Average 18.61
20-Day Moving Average 15.87
10-Day Moving Average 14.89
Average True Range 1.04
ADX 40.14
+DI 6.09
-DI 27.78
Chandelier Exit (Long, 3 ATRs) 15.65
Chandelier Exit (Short, 3 ATRs) 16.13
Upper Bollinger Bands 18.28
Lower Bollinger Band 13.45
Percent B (%b) -0.05
BandWidth 30.48
MACD Line -1.33
MACD Signal Line -1.17
MACD Histogram -0.1537
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.21
Resistance 3 (R3) 14.25 13.97 14.04
Resistance 2 (R2) 13.97 13.71 13.94 13.99
Resistance 1 (R1) 13.59 13.56 13.45 13.54 13.93
Pivot Point 13.30 13.30 13.23 13.28 13.30
Support 1 (S1) 12.92 13.05 12.78 12.88 12.49
Support 2 (S2) 12.64 12.89 12.61 12.43
Support 3 (S3) 12.26 12.64 12.38
Support 4 (S4) 12.21